FDA has approved a number of new animal drugs in the first three months of the year, which it summarized in a new rule issued July 7.
Most notably, Zoetis’s DECTOMAX, which can be used to combat New World screwworm and other parasitic pests, was supplementally approved for beef cattle in March. There was an emergency use authorization to use it for screwworm prevention for dairy cattle, horses, swine, sheep and deer in May.
Some drugs were approved to be generic copies of other drugs: Parnell Techologies’ nixiFLOR, Norbrook Laboratories’ Defendazole, Baxter Healthcare’s ANIRANE, and Felix Pharmaceuticals’ Firocoxib Tablets for Horses. Intervet’s EXZOLT Cattle and Elanco’s Rumensin 113 were conditionally approved.
Ownership of a pair of drugs, CYCLEGUARD and MONOVET, was transferred from Zoetis to Phibro. The drugs are feed additives for heifers that are intended to increase weight gain and improve feed efficiency while reducing diseases.
Dechra and Med-Pharmex collectively were granted removal of six drugs from the approval list because the drugs were no longer marketed.
